New York based Levi & Korsinsky announces that a class action lawsuit has been commenced on behalf of shareholders of Seres Therapeutics, Inc. (NASDAQ: MCRB) who purchased their shares between June 25, 2015 and July 29, 2016.
The complaint alleges that Seres Therapeutics made materially false and misleading positive statements about the …View the full post at: Levi & Korsinsky, LLP Announces Class Action Lawsuit on Behalf of Seres Therapeutics (MCRB) Shareholders …
Related Articles:
Levi & Korsinsky, LLP Announces Investigation Into the Sale of Mentor Graphics (MENT) to Siemens
